The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis
Open accessAbstract
Infection usually leads to the development of acquired immune responses associated with clearance or control of the infecting organism. However, if not adequately regulated, immune-mediated pathology can result. Tuberculosis is a worldwide threat, and development of an effective vaccine requires that the protective immune response to Mycobacterium tuberculosis (Mtb) be dissected from the pathological immune response. This distinction is particularly important if new vaccines are to be delivered to Mtb-exposed individuals, as repeated antigenic exposure can lead to pathological complications. Using a model wherein mice are vaccinated with bacille Calmette-Guérin after Mtb infection, we show that repeated vaccination results in increased IL-17, tumor necrosis factor, IL-6, and MIP-2 expression, influx of granulocytes/neutrophils, and lung tissue damage. This pathological response is abrogated in mice deficient in the gene encoding IL-23p19 or in the presence of IL-17–blocking antibody. This finding that repeated exposure to mycobacterial antigen promotes enhanced IL-17–dependent pathological consequences has important implications for the design of effective vaccines against Mtb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., et al. (2007) · Nature Immunology · doi:10.1038/ni1449 · Cited by 1,439
Self-citationPhagocytosis of Apoptotic Neutrophils Regulates Granulopoiesis via IL-23 and IL-17
Stark, M. A., Huo, Y., Burcin, T. L., Morris, M. A., Olson, T. S., & Ley, K. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.011 · Cited by 947
Global epidemiology of tuberculosis
Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68384-0 · Cited by 716
Th17 Cell Differentiation: The Long and Winding Road
McGeachy, M. J., & Cua, D. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.001 · Cited by 701
THE PATHOGENESIS OF TUBERCULOSIS
(1952) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1952.tb94689.x · Cited by 692
North, R. J., & Jung, Y.-J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance
Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L., Vacca, C., Conte, C., Mosci, P., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737409 · Cited by 555
Eum, S.-Y., Kong, J.-H., Hong, M.-S., Lee, Y.-J., Kim, J.-H., Hwang, S.-H., Cho, S.-N., Via, L. E., & Barry, C. E. (2010) · Chest · doi:10.1378/chest.09-0903 · Cited by 548
Umemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3786 · Cited by 519
Khader, S. A., Pearl, J. E., Sakamoto, K., Gilmartin, L., Bell, G. K., Jelley-Gibbs, D. M., Ghilardi, N., deSauvage, F., & Cooper, A. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.788 · Cited by 472
Self-citationInnate immune recognition of infected apoptotic cells directs TH17 cell differentiation
Torchinsky, M. B., Garaude, J., Martin, A. P., & Blander, J. M. (2009) · Nature · doi:10.1038/nature07781 · Cited by 364
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.271.9.698 · Cited by 355
Does the efficacy of BCG decline with time since vaccination?
Sterne, J. A. C., Rodrigues, L. C., & Guedes, I. N. (1998) · PubMed · Cited by 310
Eruslanov, E. B., Lyadova, I. V., Kondratieva, T. K., Majorov, K. B., Scheglov, I. V., Orlova, M. O., & Apt, A. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1744-1753.2005 · Cited by 289
Snider, D. E., Raviglione, M., & Kochi, A. (2014) · Tuberculosis · doi:10.1128/9781555818357.ch1 · Cited by 288
Cruz, A., Khader, S. A., Torrado, E., Fraga, A., Pearl, J. E., Pedrosa, J., Cooper, A. M., & Castro, A. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1416 · Cited by 288
Self-citationMiyamoto, M., Prause, O., Sjöstrand, M., Laan, M., Lötvall, J., & Lindén, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4665 · Cited by 281
IL-23 and IL-17 in tuberculosis
Khader, S. A., & Cooper, A. M. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.022 · Cited by 279
Self-citationDesvignes, L., & Ernst, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.10.007 · Cited by 246
Redford, P. S., Boonstra, A., Read, S., Pitt, J., Graham, C., Stavropoulos, E., Bancroft, G. J., & O'Garra, A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040433 · Cited by 233
Fortsetzung der Mittheilungen über ein Heilmittel gegen Tuberculose
Koch, R. (1891) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1206198 · Cited by 207
Keller, C., Hoffmann, R., Lang, R., Brandau, S., Hermann, C., & Ehlers, S. (2006) · Infection and Immunity · doi:10.1128/iai.00057-06 · Cited by 165
The Pathogenesis of Tuberculosis
Rich, A. R. (1944) · Southern Medical Journal · doi:10.1097/00007611-194410000-00018 · Cited by 140
Sander, C. R., Pathan, A. A., Beveridge, N. E. R., Poulton, I. D., Minassian, A. M., Alder, N. C., van Wijgerden, J., Hill, A. V. S., Gleeson, F. V., Davies, R. J. O., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1486oc · Cited by 125
Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis
Taylor, J. L., Turner, O. C., Basaraba, R. J., Belisle, J. T., Huygen, K., & Orme, I. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.2192-2198.2003 · Cited by 120
Turner, J., Rhoades, E. R., Keen, M. A., Belisle, J. T., Frank, A. A., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1706-1709.2000 · Cited by 109
Huygen, K., Lozes, E., Gilles, B., Drowart, A., Palfliet, K., Jurion, F., Roland, I., Art, M., Fauville‐Dufaux, M., & Nyabenda, J. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.363-370.1994 · Cited by 104
Mycobacterial Antigens Exacerbate Disease Manifestations inMycobacterium tuberculosis-Infected Mice
Moreira, A. L., Tsenova, L., Aman, M. H., Bekker, L., Freeman, S. L., Mangaliso, B., Schröder, U., Jagirdar, J. S., Rom, W. N., Tovey, M. G., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.2100-2107.2002 · Cited by 95
Persistence of the immune response induced by BCG vaccination
Weir, R. E., Gorak‐Stolinska, P., Floyd, S., et al. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-9 · Cited by 84
Torrado, E., Fraga, A. G., Logarinho, E., Martins, T. G., Carmona, J. A., Gama, J. B., Carvalho, M. A., Proença, M. F. R. P., Castro, A. G., & Pedrosa, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902717 · Cited by 66
Self-citationOrme, I. M. (1999) · Elsevier eBooks · doi:10.1016/b978-012775390-4/50174-3 · Cited by 22
Cited by
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Revisiting the role of the granuloma in tuberculosis
Ramakrishnan, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3211 · Cited by 883
Diverse novel functions of neutrophils in immunity, inflammation, and beyond
Mócsai, A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122220 · Cited by 674
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O'Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 472
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
Ottenhoff, T. H. M., & Kaufmann, S. H. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002607 · Cited by 455
Metadata
- Authors
- Cruz, A., Fraga, A. G., Fountain, J. J., Rangel-Moreno, J., Torrado, E., Saraiva, M., Pereira, D. R., Randall, T. D., Pedrosa, J., Cooper, A. M., & Castro, A. G.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-07-12
- Volume
- 207
- Issue
- 8
- Pages
- 1609-1616
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2118877744
- Cited by
- 256
- References
- 34
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.